Skip to main content
. 2021 Jul 29;10(15):3356. doi: 10.3390/jcm10153356

Figure 4.

Figure 4

The proportions of B lymphocyte maturation for each patient with CVID with complicated phenotype (CVID-C) group, CVID phenotype limited to only infections (CVID-OI group), patients with SLE, and healthy controls (HCs). Data expressed as a median percentage (%).